GL9 Glanbia plc

21.16USD19.25 EUR · ISE-0.72%Mkt Cap: 5.11B USDP/E: 23.19

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-t…

Institutional holders11 on file

Key Statistics

Company
Market Cap5.11B USD
Enterprise Value6.03B USD
Revenue (TTM)4.10B USD
Gross Profit1.06B USD
Net Income (TTM)183.30M USD
Revenue/Share16.80 USD
Last Price21.16 USD
Fiscal Year EndJan 2026
MR QuarterJul 2026
Employees5.0K
CountryIE
SectorConsumer Defensive
IndustryPackaged Foods
ISINIE0000669501
Valuation
P/E (Trailing)23.19
P/E (Forward)12.50
PEG9.04
EV/EBITDA11.25
EV/Revenue1.47
P/S1.14
P/B2.75
EPS (TTM)0.83 USD
EPS (Forward)1.54 USD
52W Range
15.4947% of range27.59
52W High27.59 USD
52W Low15.49 USD
Profitability
Gross Margin26.90%
Oper. Margin9.58%
EBITDA Margin11.89%
Profit Margin4.64%
ROE9.51%
ROA4.61%
ROIC9.38%
ROCE9.95%
Growth
Revenue Growth7.90%
Earnings Growth63.70%
Cash Flow & Leverage
Operating CF368.50M USD
CapEx (TTM)84.80M USD
FCF Margin8.19%
FCF Yield6.56%
Net Debt832.20M USD
Net Debt/EBITDA1.71
Net Debt/FCF2.48
Balance Sheet
Debt/Equity0.58
Current Ratio1.53
Quick Ratio0.84
Book Value/Sh6.99 USD
Cash/Share1.56 USD
Dividends
Fwd Div Rate0.49 USD
Trail. Div Rate0.59 USD
Div. Yield2.23%
5Y Avg Yield2.40%
Payout Ratio51.31%
Ex-Div DateAug 20, 2026
Pay Date—
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)26.46 USD
Upside (mean)+25.1%
Target Range21.58 USD – 30.86 USD
21.58+25.1% to mean30.86
# Analysts10
Ownership
Shares Out.241.69M
Float208.63M
Insiders14.37%
Institutions34.53%
Technical
SMA 5022.09 (-4.2%)
SMA 20022.30 (-5.1%)
Beta0.43
S&P 52W Chg8.68%
Avg Vol (30d)517.16K
Avg Vol (10d)510.67K
Technical Indicators
RSI (14)41.4
MACD-0.1853
MACD Signal-0.0949
MACD Hist.-0.0903
BB Upper23.61 USD
BB Middle22.18 USD
BB Lower20.75 USD
BB Width12.92%
ATR (14)0.6462 USD
Vol Ratio (20d)1.18x

About Glanbia (ISE: GL9)

›

Glanbia (ISE: GL9) is listed on Euronext Dublin, where its shares trade in EUR. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 4,963 employees.

The shares were at 19.25 EUR on 20 November 2026, up 34.0% over 52 weeks. Its 52-week range is 14.09 EUR to 25.10 EUR: the price is 23.3% below the high and 36.6% above the low.

At a market capitalisation of 4.65B EUR, it trades at 23.2 times trailing earnings and 12.5 times forward earnings. The median trailing P/E of its 18 largest Packaged Foods peers is 24.8, so GL9 is valued in line with them. It pays a dividend yielding 2.23% (it pays out 51% of its earnings), against a median of 3.67% among the dividend payers in that peer group.

Glanbia reports return on equity of 9.5%, an operating margin of 9.6% and revenue up 7.9% year over year.

Its debt exceeds its cash by 832.20M USD, a debt-to-equity ratio of 0.58. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 10 analysts cover the stock, with an average rating of Buy; their mean price target of 24.07 EUR is 25.1% above the current price. The next earnings report is expected on 24 February 2027.